Tudyka J, Wechsler J G, Kratzer W, Maier C, Mason R, Kuhn K, Adler G
Krankenhaus der Barmherzigen Bruder, Department of Internal Medicine, Munich, Germany.
Dig Dis Sci. 1996 Feb;41(2):235-41. doi: 10.1007/BF02093810.
After successful dissolution therapy of cholesterol gallbladder stones bile again becomes supersaturated and recurrent gallstones may develop. Three different postdissolution treatments [500 mg ursodeoxycholic acid (UDCA) per day (N = 14, group I), 100 mg aspirin per day (N = 14, group II) and diet (N = 15, group III) versus a control group (no treatment, N = 15, group IV) aimed at preventing recurrence of gallstones were investigated in a prospective, randomized study in 58 gallstone patients (33 female, 25 male) after complete stone clearance. Bile samples (prior to dissolution therapy and at stone recurrence) were investigated for biliary cholesterol (C), phospholipids (PL), total bile acid concentration (BA), cholesterol saturation index (CSI), total lipid concentration (TLC), total biliary protein concentration (TP), and nucleation time (NT). In group IV multiple gallstones tended to recur more often than solitary stones (66.7% vs 16.7%) whereas in groups I-III only solitary stones recurred. Recurrent gallbladder stones were detectable in 10 patients (eight patients in group IV and one each in groups I and II, respectively) within one year after dissolution and in two patients (one each in groups III and IV, respectively) after 15 months. Furthermore, the probability of stone recurrence was significantly higher in untreated patients as compared to treated patients. In nine (group IV) of 12 patients with recurrent stones NT, C, CSI, PL, BA, TLC, TP, and bile acid spectrum remained nearly unchanged as compared to their pretreatment values, whereas in three (groups I-III) of 12 cases a decrease in C, CSI, and TP was observed during therapy. However, in each of these three patients, initial and after-treatment TP was significantly higher and NT shorter as compared to groups I-IV. Furthermore, in these cases (N = 3) NT was prolonged, whereas no significant changes were found in PL, BA, TLC, and bile acid spectrum. Recurrence of gallstones, which seems to occur more likely in patients with multiple stones as compared to solitary stones, will happen in the early stage after stone clearance, again causing biliary pain. UDCA, aspirin or diet will reduce the probability for recurrent stones after complete gallstone dissolution.
在胆固醇性胆囊结石成功进行溶石治疗后,胆汁会再次变得过饱和,可能会形成复发性胆结石。在一项针对58例胆结石患者(33例女性,25例男性)的前瞻性随机研究中,在结石完全清除后,研究了三种不同的溶石后治疗方法[每天500毫克熊去氧胆酸(UDCA)(第I组,N = 14)、每天100毫克阿司匹林(第II组,N = 14)和饮食控制(第III组,N = 15)]与对照组(不进行治疗,第IV组,N = 15)预防胆结石复发的效果。对胆汁样本(溶石治疗前和结石复发时)进行了胆汁胆固醇(C)、磷脂(PL)、总胆汁酸浓度(BA)、胆固醇饱和指数(CSI)、总脂质浓度(TLC)、总胆汁蛋白浓度(TP)和成核时间(NT)的检测。在第IV组中,多发结石比单发结石更容易复发(66.7%对16.7%),而在第I - III组中只有单发结石复发。在溶石后1年内,10例患者(第IV组8例,第I组和第II组各1例)可检测到复发性胆囊结石,15个月后有2例患者(第III组和第IV组各1例)出现复发性结石。此外,未治疗患者结石复发的概率明显高于治疗患者。在12例复发性结石患者中,9例(第IV组)的NT、C、CSI、PL、BA、TLC、TP和胆汁酸谱与治疗前相比几乎没有变化,而在12例患者中的3例(第I - III组)在治疗期间观察到C、CSI和TP有所下降。然而,在这3例患者中,与第I - IV组相比,初始和治疗后的TP明显更高,NT更短。此外,在这些病例(N = 3)中NT延长,而PL、BA、TLC和胆汁酸谱没有明显变化。与单发结石患者相比,多发结石患者似乎更易出现胆结石复发,且复发多发生在结石清除后的早期阶段,再次引起胆绞痛。UDCA、阿司匹林或饮食控制可降低胆结石完全溶解后复发的概率。